Appleyard Lees

Life Sciences & Biotechnology

The Life Sciences sector is rapidly evolving and now delivering the next generation of therapies and diagnostics. It is not surprising that pharmaceutical companies are starting to divert resources and filing more patent applications in this area. Momentum is gathering pace and patent laws around the world struggle to keep up at times with new the technologies being developed.

We keep a close eye on developments in Europe and further afield so that we can ensure that our advice and the patents we draft are fit for domestic and overseas markets in which our clients operate. We also help our foreign associates and clients keep up to date with developments in Europe by providing information on recent cases and current practices. For more detailed information follow the links below.

Date Exclusivity
Supplementary Protection Certificates
First and Second Medical Use
Active Ingredients
Biological Deposits
Biosimilars and Biobetters
Clinical trial exemptions from infringement (Bolar Exemptions)
Industrial Biotechnology
Medical Devices
Pharmaceuticals and Parallel Importation in the EU
Screening Assays
Sequence Listings
Stem Cells

We cover a vast array of Life Science technologies and all of our attorneys have worked in laboratories undertaking research and are keen to learn and get involved with new and innovative cutting-edge technologies. Our attorneys are collaborative by nature and we have the right mix of attorneys in our firm to handle hybrid technologies such as bio-electric sensors, medical diagnostic devices and bioinformatics.

We act for a number of multinational corporations, well known brands and Universities, as well as SMEs, and we have a well-earned reputation for handling complex technical subject matter and providing clear and strategic advice on the best options to maximise your return on investment in protecting your innovations.

We publish our well respected Applepip Life Sciences & Pharmaceutical newsletter twice a year which provides our clients and foreign attorneys with details of relevant case-law in the UK and Europe and highly relevant global developments.  To view click March 2014October 2014 or April 2015

Members of:

BIA Member Logo           Bionow1

Simon BradburyPartner